v3.25.2
Financial instrument
11 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2025
IfrsStatementLineItems [Line Items]    
Financial instrument

8. Financial instrument

 

The following table analyses the financial assets and liabilities in the statement of financial position by the class of financial instruments to which they are assigned, and therefore by the measurement basis:

   2025 
   USD 
     
Financial assets     
At amortised cost     
Cash on hand   1 
      
Financial liabilities     
At amortised cost     
Other payables and accrued expenses   18,503 

 

Financial risk management objectives and policies

 

The Company is exposed to financial risk arising from its operations and the use of financial instruments. The key financial risk is liquidity risk.

 

The following sections provide details regarding the Company’s exposure to the above-mentioned financial risks and the objectives, policies and processes for the management of the risk.

 

Liquidity risk

 

Liquidity risk is the risk that the Company encounters difficulty in meeting its obligations due to shortage of funds. The Company’s exposure to liquidity risk arises primarily from other payables.

 

The Company’s funding requirements and liquidity risk are managed with the objective of meeting business obligations on a timely basis. The Company manages liquidity risk by maintaining adequate reserves and banking facilities by continuously monitoring forecast and actual cash flows, and by matching the maturity profiles of financial assets and liabilities.

 

All financial liabilities of the Company are assessed as current and correspondingly, no detailed maturity analysis is deemed necessary.

 

Fair values of financial instruments

 

The carrying amounts of short-term payable and cash and cash equivalents approximate their fair value due to the relatively short-term nature of these financial instruments and insignificant impact of discounting.

 

 

 
Alps Life Science Inc [Member]    
IfrsStatementLineItems [Line Items]    
Financial instrument  

 

29. Financial instrument

 

The following table analyses the financial assets and liabilities in the statement of financial position by the class of financial instruments to which they are assigned, and therefore by the measurement basis:

   2025   2024 
   USD   USD 
         
Financial assets          
At amortised cost          
Trade receivables   45,528    74,016 
Other receivables and deposits   267,146    200,920 
Amount due from associates   18,435    2,145 
Cash and bank balances   318,932    460,467 
           
Financial assets   650,041    737,548 

 

 

29. Financial instrument (Cont’d)

 

The following table analyses the financial assets and liabilities in the statement of financial position by the class of financial instruments to which they are assigned, and therefore by the measurement basis: (Cont’d)

 

   2025   2024 
   USD   USD 
         
Financial liabilities          
At amortised cost          
Trade payables   321,350    175,599 
Other payables and accruals   864,910    849,451 
Amount due to associates   20,763    - 
Amount due to directors   5,972,257    3,610,711 
Hire purchase liabilities   -    7,260 
Lease liabilities   961,875    500,308 
           
Financial liabilities   8,141,155    5,143,329 

 

Financial risk management objectives and policies

 

The Group is exposed to financial risk arising from its operations and the use of financial instruments. The key financial risks include credit risk and liquidity risk.

 

The following sections provide details regarding the Group’s exposure to the above-mentioned financial risks and the objectives, policies and processes for the management of those risks.

 

(i)Credit risk

 

Credit risk is the risk of a financial loss to the Group that may arise if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Group’s exposure to credit risk mainly from trade receivables, other receivables and refundable deposits and amount due from associates.

 

The management has in place a credit procedure to monitor and minimises the exposure of default. Receivables are monitored on a regular and an ongoing basis. Credit evaluations are performed on all customers requiring credit over certain amount.

 

For cash and cash equivalents, the Group minimises credit risk by dealing exclusively with high credit rating counterparties.

 

The Group provides advances to associates. The Group monitors the results of the associates regularly.

 

Exposure to credit risk

 

The carrying amount of the financial assets recorded on the consolidated statement of financial position at the end of the reporting period represents the Group’s maximum exposure to credit risk in relation to financial assets. No financial assets carry a significant exposure to credit risk.

 

 

29. Financial instrument (Cont’d)

 

Financial risk management objectives and policies (Cont’d)

 

(ii)Liquidity risk

 

Liquidity risk is the risk that the Group encounters difficulty in meeting its obligations due to shortage of funds. The Group’s exposure to liquidity risk arises primarily from trade payables, other payables and accruals, amounts due to directors, hire purchase liabilities and lease liabilities.

 

The Group’s funding requirements and liquidity risk are managed with the objective of meeting business obligations on a timely basis. The Group manages liquidity risk by maintaining adequate reserves and banking facilities by continuously monitoring forecast and actual cash flows, and by matching the maturity profiles of financial assets and liabilities.

 

Analysis of financial instruments by remaining contractual maturities

 

The table below summarises the maturity profile of the Group’s financial liabilities at the end of the reporting period based on undiscounted contractual payments:

 

   Interest rate   Total carrying
amount
   On demand or
within 1 year
   Within 2 to 5 years   Total undiscounted cash flow 
   %   USD   USD   USD   USD 
                     
2025                         
Non-interest bearing:                         
Trade payables   -    321,350    321,350    -    321,350 
Other payables and accruals   -    878,421    878,421    -    878,421 
Amount due to associates   -    20,763    20,763    -    20,763 
Amount due to directors   -    5,972,257    5,972,257    -    5,972,257 
                          
Interest bearing:                         
Lease liabilities   6.65    961,875    499,557    535,578    1,035,135 
                          
         8,154,666    7,692,348    535,578    8,227,926 

 

 

29. Financial instrument (Cont’d)

 

(ii)Liquidity risk (Cont’d)

 

Analysis of financial instruments by remaining contractual maturities (Cont’d)

 

The table below summarises the maturity profile of the Group’s financial liabilities at the end of the reporting period based on undiscounted contractual payments: (Cont’d)

 

   Interest rate   Total carrying amount   On demand or
within 1 year
   Within 2 to 5 years   Total undiscounted cash flow 
   %   USD   USD   USD   USD 
                     
2024                         
Non-interest bearing:                         
Trade payables   -    175,599    175,599    -    175,599 
Other payables and accruals   -    956,063    956,063    -    956,063 
Amount due to directors   -    3,610,711    3,610,711    -    3,610,711 
                          
Interest bearing:                         
Hire purchase liabilities   4.55    7,260    7,384    -    7,384 
Lease liabilities   7.04    500,308    329,071    202,421    531,492 
                          
         5,249,941    5,078,828    202,421    5,281,249 

 

Fair values of financial instruments

 

The carrying amounts of short-term receivables and payables and cash and cash equivalents approximate their fair value due to the relatively short-term nature of these financial instruments and insignificant impact of discounting.

 

The fair value of hire purchase liabilities and lease liabilities are determined by discounting the relevant cash flows using current interest rates for similar instruments as at the end of the financial reporting period.